A biomarker panel can improve prediction of chronic kidney disease progression in children aged 6 months to 16 years.

Cutting prevention isn’t fiscal discipline—it’s like selling your emergency generator before hurricane season to make a quick buck.

NEW CASTLE, DE, UNITED STATES, June 27, 2025 /EINPresswire.com/ -- Allied Market Research published its latest report analyzing the Flooring Wood Panels market, which emphasizes on the factors ...

For Arkansas Children’s, the impetus for growth is about more than physical expansion — it’s about reaching children who need healthcare in a rural and sparsely populated state. The two-hospital, ...

The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as ...

Phathom gains FDA exclusivity for VOQUEZNA through 2032, boosting stock. DCF values shares at $14 with 43% upside potential.

Advancement of long lead work programs to support ML Application HIGHLIGHTS Recent Tunkillia OSS confirms large-scale gold ...

Bayi 8 bulan belum tumbuh gigi, apakah sesuatu yang normal atau merupakan masalah pertumbuhan? Baca artikel ini untuk ...

Ambience Healthcare becomes the only ambient AI to deliver comprehensive patient context before encounters, extending beyond ...

GeneDx stock jumped again Tuesday after the American Academy of Pediatrics green-lit genetic testing for a larger pool of children.

GeneDx Holdings Corp. leverages genomics leadership with robust growth, despite recent stock challenges. Click for more on ...

The connections a baby's brain forms during the first two years of life, coupled with a baby's genetic makeup, offer a window ...